CIK: 0001910264
Total reported value
$915.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | Stock-Other | 44.83% | +7.77% | -25.42% | |
| 2 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 19.64% | -4.55% | — | |
| 3 | SPRY | Ars Pharmaceuticals INC | Stock-Other | 11.26% | -3.10% | — | |
| 4 | NKTX | Nkarta INC | Stock-Other | 9.90% | -0.10% | +150.00% | |
| 5 | DSGN | Design Therapeutics INC | Stock-Other | 7.22% | -1.08% | — | |
| 6 | MLYS | Mineralys Therapeutics INC | Stock-Other | 7.15% | -3.40% | +12.38% |